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Abstract 
The DNA repair capacity in the mature spermatozoa is highly compromised due to the Base 
Excision Repair Route (BER) being truncated. In the mature spermatozoa only the first enzyme 
of the route (OGG1) is present. Consequently, reduced activity of the enzymes of the BER route 
both during spermatogenesis and in the mature spermatozoa may be detrimental for fertility. 
The objective of our study was to investigate the correlation between two representative SNPs 
of those enzymes, SNPs OGG1 Ser326Cys (rs1052133) and XRCC1 Arg399Gln (rs25487) and male 
infertility. 313 seminal samples from infertile patients and 80 from donors with proven fertility 
were included in the study. All samples were subjected to a regular sperm analysis and 
genotyped using the PCR-RFLP system. We found significant differences in the genotype 
frequencies between patients and donors for the XRCC1 Arg399Gln polymorphism (χ2(2)=8.7, 
P=0.013), with the Gln allele showing a protective role and for the OGG1 Ser326Cys 
polymorphism between normozoospermic and non-normozoospermic patients (χ2(2)=12.67, 
P=0.002) with the Cys allele showing a detrimental effect over concentration. In conclusion, our 
study shows that polymorphisms in the genes coding for the DNA damage repair enzymes may 
be associated with poor sperm parameters and male infertility. 
Introduction 
Reactive oxygen species (ROS) are free radicals that have at least one unpaired electron (Rahal, 
Kumar et al. 2014). ROS originate as by-products of the metabolism of oxygen and are normally 
neutralized by the antioxidant systems. However, occasionally an elevated production of ROS or 
a failure in the antioxidant systems leads to an increase in ROS concentration. Under this 
situation elevated levels of ROS can cause both DNA damage and lipid peroxidation (Agarwal, 
Virk et al. 2014). One of the main effects of oxidative stress affecting sperm DNA quality is the 
oxidation of guanine bases producing 8-hydroxy-2´-deoxyguanosine (8-OHdG) which is a highly 
mutagenic element leading to a G:C → T:A transversion after replication (Wood, Wood et al. 
1992). 
The Base Excision Repair System (BER) is the DNA repair pathway that detects and repairs the 
presence of 8OHdG residues in the DNA (Olsen, Lindeman et al. 2005). Two principal enzymes 
in this pathway are the 8-oxoguanine glycosylase 1 (OGG1) and the X-ray repair cross 
complementing group 1 (XRCC1). The OGG1 is the first enzyme in the route and the one that 
detects the presence of the 8OHdG residues and eliminates them, producing an abasic site while 
the XRCC1 is a scaffold enzyme that attracts the rest of the implicated enzymes to the newly 
abasic site and coordinates them, enhancing the effectiveness of the pathway. 
In contrast to somatic cells, in the mature spermatozoa the BER route is truncated, being only 
the OGG1 enzyme active (Smith, Dun et al. 2013). Due to this situation, a proper functioning of 
the BER pathway during spermatogenesis is essential in order to obtain mature spermatozoa 
with the lowest levels of 8-OHdG residues possible, as the remaining 8-OHdG residues cannot 
be completely repaired in the mature spermatozoa. Moreover, as the OGG1 enzyme is active in 
the mature spermatozoa and the rest of the pathway is truncated, its activity on the remaining 
8-OHdG residues leads to the presence of abasic sites in the DNA of the fertilizing spermatozoa 
which may be detrimental to the fertilization process (González-Marín, Gosálvez et al. 2012).  
However, little information is available regarding the relationship between polymorphisms in 
those critical enzymes and the consequences for male infertility. The objective of our study was 
to investigate the correlation between two representative SNPs located in two key enzymes of 
the BER pathway, SNPs OGG1 Ser326Cys (rs1052133) and XRCC1 Arg399Gln (rs25487) and male 
infertility.  
Materials and methods 
2.1.) Subjects and sample collection 
The study was approved by the Bioethics Committee of the University Autonoma of Madrid (CI 
60-1058). A total of 393 subjects were included in the study. The patient cohort consisted of 313 
individuals undergoing an assisted reproduction treatment that showed no evidence of any 
other fertility related diseases, such as prostate cancer, cryptorchidism, varicocele, diabetes, 
seminal infections or karyotype abnormalities. The control cohort included 80 individuals with 
proven fertility who had already fathered at least one child. Each subject donated 1mL of semen 
obtained by masturbation after at least 4 days of abstinence (the regular abstinence period 
applied in the collaborating clinic). 
2.1) Seminal analysis 
To get a general overview of the seminal quality in our population a regular sperm analysis was 
performed for each sample according to World Health Organization (WHO) guidelines (World 
Health Organization 2010). The included parameters were volume, concentration, motility, 
morphology and vitality. The individuals included in the patient cohort were classified into 
normozoospermic and non-normozoospermic according to cut-off reference values for seminal 
characteristics as published in the WHO 2010 laboratory manual for the examination and 
processing of human semen (for non-normozoospermic volume ≤ 1.5mL, concentration ≤ 15 mill 
mL-1, motility ≤ 40%, morphology ≤ 4% and vitality  ≤ 58%). 
2.2) Sperm DNA fragmentation 
Sperm DNA fragmentation was assessed for all samples in the patient cohort using the Sperm 
Chromatin Dispersion Assay (SCD) in the form of the Halosperm Kit (Halosperm Kit, Halotech 
DNA, Madrid, Spain) and in accordance with the manufacturer’s guidelines. Briefly, seminal 
samples were included in an agarose microgel on a microscope slide and they were next 
subjected to a lysis solution and a deproteinization solution. After being washed and dehydrated 
with alcohols all samples were stained with SYBR-Green (SYBR-Green 10000x, Cat No S7563, 
Thermo Fisher Scientific, Braunschweig, Germany), mounted with Vectashield (Vectashield 
Mounting Medium, Cat No H-1000, Vector Laboratories, Burlingame, USA) and observed with 
fluorescence microscopy (Leica DMRB, Leica-Mycrosystems, Wetzlar, Germany). 
2.3) DNA extraction 
DNA extraction was performed using the phenol-chloroform method with proteinase-K 
treatment as described elsewhere with minor modifications (Yuan, Kuete et al. 2015). Briefly, 
500 µL of liquefied semen was centrifuged at 1800 rpm and the pellet re-suspended in 100 µL 
of seminal plasma. This sample was then incubated overnight in a solution consisting of 8 µL 10 
mg mL-1 proteinase K (Proteinase K Recombinant PCR Grade, Cat No 03 115 887 001, Roche, 
Mannheim, Germany), 8 µL of 1M DTT and 100 µL extraction buffer (20mM Tris-Cl, 20mM EDTA, 
200mM NaCl, 4% SDS). Thereafter, 216 µL of phenol (Phenol/Chloroform/Isoamyl alcohol 
25:24:1, Cat No 327115000, Acros Organics, New Jersey, USA) was added to the semen sample 
and the mixture agitated by a mechanical shaker for 2 min after which it was centrifuged at 8000 
rpm for 10 min. The upper aqueous phase was then recovered and the same operation 
performed with 200 µL of chloroform:isoamil 24:1 (Chloroform reagent grade - Cat No 
CL02031000, Scharlab, Spain; Isoamylalcohol >98% - Cat No 818969, Merck, Munich, Germany). 
The upper aqueous phase was then recovered once more to which 250 µL of cold (-20 ºC) 100% 
ethanol was also added. This solution was shaken gently until the DNA precipitated and the 
sample was left to stand overnight at -20 ºC. The DNA was then washed with cold (-20 ºC) 70% 
ethanol and air-dried. To eliminate contaminating RNA, the pellet was re-suspended in 50 µL of 
TRIS-EDTA buffer with 0.5 µL of 1 mg mL-1 RNAse (RNase DNase free, Cat No 11 119 915 001, 
Roche, Mannheim, Germany) and incubated for 2 h at 37 ºC. Finally, the concentration of the 
extracted DNA was determined using a NanoDrop ND-1000 (Thermo Scientific, Braunschweig, 
Germany) before diluting to a concentration of 50 ng µL-1 and stored at 4 ºC. 
2.4) Genotype analysis 
The OGG1 Ser326Cys and XRCC1 Arg399Gln genotypes were determined using the polymerase 
chain reaction-restriction fragment length polymorphism (PCR-RFLP) method according to the 
protocols by Sobczuk et al (Sobczuk, Poplawski et al. 2012) and Lunn et al (Lunn, Langlois et al. 
1999) respectively. The PCR protocol was performed as follows: initial denaturation (94 °C, 10 
min) followed by 35 cycles of denaturation (94 °C, 30 s), annealing (melting temperature, 30 s) 
and elongation (72 °C, 30 s).  The PCR products were then digested with the restriction enzymes 
SatI and MspI respectively (both FastDigest Restriction Enzymes, Cat Nos SatI-FD1644 and MspI-
FD0544, Thermo Scientific, Braunschweig, Germany) by incubation at 37 ºC for 45 min. The 
primer sequences and the restriction enzymes are shown in table 1. 
2.5) Statistical analysis 
Statistical analysis was performed using the SPSS 22 software for Windows (SPSS Inc., Chicago. 
USA). Adjustment of continuous variables to normal distribution was checked using the 
Kolmogorov-Smirnov test. A goodness-of-fit Chi square test was used to determine the Hardy-
Weinberg equilibrium of the observed genotype frequencies. Associations between categorical 
variables (genotype frequencies and odds ratios) were assessed using the Chi-square test. 
Continuous variables (seminal parameters) were compared between genotypic groups using the 
non-parametric test Kruskal-Wallis. A P value <0.05 was considered to be statistically significant. 
Results 
We obtained data from 393 subjects: 313 infertile patients and 80 controls with proven fertility. 
Table 2 describes the demographic and clinical profile of the participants. The genotype 
frequencies of the studied polymorphisms are shown in table 3. Both cohorts were in Hardy-
Weinberg equilibrium for both polymorphisms. We only found significant differences between 
patients and donors for the XRCC1 Arg399Gln polymorphism (χ2(2)=8.7, P=0.013). Similarly, as 
showed in figure 1, we only got statistically significant odds ratios of infertility for the SNP XRCC1 
Arg399Gln and the genotypes Arg/Arg (OR=2.223, 95% CI=1.296-3.813, χ2(1)=8.67, P=0.003) and 
Arg/Gln (OR=0.555, 95%CI=0.337-0.912, χ2(1)=5.47, P=0.019). 
When we compared the values of the traditional sperm analysis between genotypes we 
obtained significant differences for the parameter concentration and the SNP XRCC1 Arg399Gln 
(H=8.43, P=0.015) (see table 4). Pairwise comparisons revealed significant differences between 
genotypes Arg/Arg and Gln/Gln (H=-43.23, P=0.047, r=-0.131) and differences approaching 
significance between genotypes Arg/Arg and Arg/Gln (H=-28.98, P=0.056, r=-0.159). We also 
obtained differences approaching significance for the SNP OGG1 Ser3226Cys and the parameter 
morphology. Moreover, for the SNP OGG1 Ser3226Cys we obtained the highest values in all 
parameters for the genotype Ser/Ser while for the SNP XRCC1 Arg399Gln we obtained the 
highest values in all parameters for the genotype Gln/Gln. In concordance, we obtained the 
lowest levels of sperm DNA fragmentation for genotypes Ser/Ser for the SNP OGG1 Ser3226Cys 
and Gln/Gln for the SNP XRCC1 Arg399Gln. 
When we classified the patients cohort according to its diagnosis (normozoospermic and non-
normozoospermic) we obtained statistically significant differences in the genotype frequencies 
between those two subgroups for SNP OGG1 Ser326Cys (χ2(2)=12.67, P=0.002) (see table 5). 
Nine possible combinations were derived from the observed genotypes, of which two of them 
(Ser/Ser-Arg/Arg and Ser/Ser-Arg/Gln) represented more than 50% of the occurrences both in 
controls and in cases (see table 6). The general distribution was not significantly different 
between infertile patients and fertile controls (χ2(8)=11.61, P=0.169). Only two combinations 
showed a statistically significant association with male fertility status: Ser/Ser-Arg/Arg 
(OR=1.915, 95% CI=1.005-3.648, χ2(1)=4.003, P=0.045) and Ser/Ser-Arg/Gln (OR=0.531, 95% 
CI=0.315-0.894, χ2(1)=5.765, P=0.016). 
Discussion 
As mentioned earlier, BER is a DNA repair pathway that detects the presence of 8-OHdG 
modified nucleotides in the DNA and repairs them. Two principal enzymes in this pathway are 
OGG1 and XRCC1. The aim of this study was to find a relationship between two representative 
SNPs of those enzymes, SNPs OGG1 Ser326Cys and XRRC1 Arg399Gln, and male infertility. 
OGG1, coded in chromosome 3p26, is the first enzyme which works in the BER DNA repair 
system. It recognizes oxo-G:C base pairs and catalyses the expulsion of the oxoG leaving an 
abasic site in the DNA (Norman, Verdine et al. 2000). The OGG1 is the only enzyme of the BER 
route present in the mature spermatozoa and its activity is essential for the repair of the oxo-
G:C base pairs. The oocyte, although being able to repair part of the DNA damage from the 
spermatozoa post fecundation, has very low concentration of this particular enzyme. It has been 
shown that semen of infertile men has an increased level of oxo-G:C base pairs (Dantzer, Bjørås 
et al. 2003). The Ser326Cys polymorphism is a C to G transversion in exon 7 in an α-helix domain 
(Kohno, Shinmura et al. 1998). Several studies have associated the Cys allele with a reduced 
repair capacity (Hill, Evans 2006), (Smart, Chipman et al. 2006). Specifically, the group of Kohno 
et al found a strong association with the Ser allele having 7 times higher enzyme activity levels 
compared to the enzyme activity produced by the Cys allele (Kohno, Shinmura et al. 1998).  
To our knowledge there is only other published study for this polymorphism related to infertility; 
they also observed a higher frequency of genotypes Ser/Cys and Cys/Cys in patients than in 
donors although their frequencies are not similar to ours (Ji, Yan et al. 2013). These differences 
can be a consequence of the differences in the number of subjects studied (they had 620 
patients and 480 donors) or of the different ethnicity of the subjects (Asiatic versus Caucasian). 
In our study, we could not find statistically significant differences in the genotype frequencies 
between patients and donors; in contrast, we have observed statistically significant differences 
in the genotype frequencies between normozoospermic and non-normozoospermic patients, 
with the latter showing a reduction in the frequency of the Ser/Ser genotype. In addition, 
although not being statistically significant, the only genotype showing an odds ratio of infertility 
under 1 (protective role) was the genotype Ser/Ser. Moreover, we obtained the highest sperm 
parameters and the lowest sperm DNA fragmentation levels for the Ser/Ser genotype with 
differences approaching a significant value for parameter morphology. Consequently, our 
observations are concordant with the hypothesis that the Cys allele correlates with a reduced 
repair capacity and point to the idea that it has a major impact on sperm morphology. A reduced 
activity of the enzyme OGG1 may correlate with a higher presence of oxo-G:C base pairs and 
thus with a defective spermiogenic procedure generating morphologically abnormal 
spermatozoa. 
XRCC1, coded in chromosome 19q13.2, is a key enzyme in the BER DNA repair system whose 
function is to attract other enzymes to the sites where the DNA is damaged (Thompson, West 
2000), (Radicella, Boiteux et al. 2001). It has been shown that its expression in the testes is higher 
than in other tissues suggesting that it may play an important role during spermiogenesis to 
repair damage from the meiosis in the DNA (Ahmed, de Boer et al. 2010), (Walter, Lu et al. 1994). 
In contrast, the XRCC1 enzyme is not present in the mature spermatozoa. Consequently, XRCC1 
enzyme deficiency during spermiogenesis would lead to the presence of damage in the DNA of 
the mature spermatozoa and this damage will pass to the embryo, as the mature spermatozoa 
has a truncated BER route and thus cannot repair it. In the Arg399Gln polymorphism there is an 
Arg to Gln substitution in codon 399 which is located in the poly ADP ribose polymerase (PARP) 
binding domain (Saadat, Ansari-Lari 2009).  
In our study we observed significant differences in the genotype frequencies between patients 
and donors with an increased presence of the heterozygous Arg/Gln genotype in fertile donors. 
Our results are consistent with those of Gu et al (Gu, Liang et al. 2007), (Gu, Ji et al. 2007) but 
there are other studies which offer an opposite conclusion (Zheng, Wang et al. 2012) or even no 
correlation between this polymorphism and idiopathic male infertility (Gashemi, Khodadadi et 
al. 2017). These differences may be as a consequence of the ethnic background of the 
population. Both the Gu et al and Zheng et al studies were conducted with Asiatic populations 
(China) while ours was conducted with a Caucasian population (Spain). Moreover, our genotype 
frequencies are consistent with those observed by Silva et al in Caucasian women (Portugal) 
(Silva, Moita et al. 2007). However, when we compared the sperm parameters between 
genotypes we obtained the highest values in all parameters for genotype Gln/Gln with 
significant differences in the case of the parameter concentration. This may indicate that the 
Arg allele might have an impact on fertility with the Arg/Arg genotype correlating with an 
important reduction in sperm concentration. A possible explanation for this observation could 
be that this variant of the enzyme would be less active, leaving more abasic sites in the sperm 
DNA and thus increasing the activation of apoptotic processes which lead to a reduction in 
sperm concentration.  In concordance with this idea, Manente et al have recently correlated the 
presence of elevated levels of sperm DNA fragmentation with an increase in apoptosis and with 
the diagnosis of oligo and necrozoospermia (Manente, Pecoraro et al. 2015).  
When combining the studied polymorphism we obtained nine possible options but only two of 
them showed a significant association with the male fertility status (Ser/Ser-Arg/Arg and 
Ser/Ser-Arg/Gln). In both cases the observed odds ratios were similar to those observed for the 
XRCC1 Arg399Gln polymorphism alone. Thus we hypothesise that the effect of the presence of 
a polymorphism is more important for the XRCC1 enzyme than for the OGG1 one. That 
observation may be explained due to the lack of activity of the XRCC1 enzyme in the mature 
spermatozoa which makes the XRCC1´s activity levels during spermatogenesis critical. 
We are aware that our study has both strengths and weaknesses. The main strengths are the 
relatively high number of individuals included in the study and that all subjects included in the 
donors’ cohort had proven fertility as they had already fathered at least one child. With respect 
to the study’s weaknesses, due to sample availability the number of individuals included in each 
cohort was not balanced, with a total of 313 patients but only 80 donors. In addition, although 
sperm parameters are influenced by patient exposure factors such as BMI, smoking and diet, 
these aspects are difficult or virtually impossible to fully define in the individual patients and 
thus we have not considered them in our study. 
In conclusion, our study shows that polymorphisms in the genes coding for the DNA damage 
repair enzymes are associated with lower enzyme activity, poor sperm parameters and male 
infertility. More research should be done including a broader spectrum of polymorphisms 
located in genes coding for the enzymes of the BER route in order to better understand their 
relation to male infertility. 
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Figure legends 
Figure 1: Forest plot of infertility risk for each genotype. Horizontal lines represent 95% CI. Each 
square represents the OR point. The vertical line is at the null value (OR=1). Statistical analysis: 
chi-square test. 
Tables 
Table 1: RFLP settings. 
Polymorphism OOG1 Ser326Cys XRCC1 Arg399Gln 
PCR primers F 5`-GGAAGGTGCTTGGGGAAT-3` 
R 5`-ACTGTCACTAGTCTCACCAG-3` 
F 5`-TTGTGCTTTCTCTGTGTCCA-3` 
R 5`-TCCTCCAGCCTTTTCTGATA-3` 
Annealing 
temperature 
56 ºC 56 ºC 
PCR product 200 bp 615 bp 
Restriction enzyme SatI MspI 
Restriction fragments Ser/Ser 200 Arg/Arg 374,221 
Ser/Cys 200,100 
Cys/Cys 100 
Arg/Gln 615,374,221 
Gln/Gln 615 
 
Table 2: Demographic and clinical profiles of the cohorts included in the study (Mean ± Standard 
deviation). Statistical analysis: Mann-Whitney U-test. 
 
Patients Donors P-value 
Volume (mL) 3.33 ± 1.36 3.19 ± 1.19 0.431 
Sperm Concentration (X 106 mL-1) 26.93 ± 18.41 53.82 ± 18.92 <0.001 
Motility (%) 38.93 ± 12.22 54.55 ± 6.36 <0.001 
Morphology (%) 3.41 ± 1.87 6.41 ± 1.71 <0.001 
DNA fragmentation (%) 19.69 ± 13.15 No data No data 
 
Table 3: Genotype frequencies of the OGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms 
among the cases and controls. Statistical analysis: Chi-square test. 
 
Patients Donors  
Genotype n (obs) Genotype  
frequency 
n (obs) Genotype  
frequency 
P-value 
OGG1 Ser326Cys 
    
 
Ser/Ser 182 0.59 53 0.66 0.455 
Ser/Cys 118 0.37 25 0.32 
Cys/Cys 13 0.04 2 0.02 
XRCC1 Arg399Gln 
    
 
Arg/Arg 144 0.46 22 0.28 0.013 
Arg/Gln 129 0.41 45 0.56 
Gln/Gln 40 0.13 13 0.16 
 
Table 4: Extended analysis of traditional seminal parameters for each genotype. The data shown 
are the mean for volume (mL), concentration (mill mL-1), motility (%), morphology (%), vitality 
(%) and DNA fragmentation (%). Statistical analysis: Kruskal-Wallis test.  
 
 
 
Genotypes p-value 
OGG1 
Ser326Cys 
 
Ser/Ser Ser/Cys Cys/Cys 
 
Volume (mL) 3.38 3.21 2.90 0.266 
Concentration 
 (mill mL-1) 
33.09 31.29 30.33 0.538 
Motility (%) 42.88 41.15 38.66 0.269 
Morphology (%) 4.20 3.73 3.66 0.056 
Vitality (%) 75.55 72.29 71.60 0.280 
Fragmentation (%) 19.19 20.44 19.87 0.688 
XRCC1 
Arg399Gln 
 
Arg/Arg Arg/Gln Gln/Gln 
 
Volume (mL) 3.29 3.29 3.34 0.957 
Concentration 
(mill mL-1) 
28.81 33.99 38.09 0.015 
Motility (%) 40.92 42.20 45.28 0.159 
Morphology (%) 3.89 4.04 4.30 0.408 
Vitality (%) 73.22 74.33 75.76 0.666 
Fragmentation (%) 19.46 20.50 17.86 0.641 
 
 
Table 5: Extended comparison of genotype frequencies of the OGG1 Ser326Cys and XRCC1 
Arg399Gln polymorphisms between controls, normozosspermic patients and non-
normozoospermic patients. Statistical analysis: Chi Square test. 
  Genotypes p-value 
OGG1 
Ser326Cys 
 Ser/Ser Ser/Cys Cys/Cys  
Donors 0.66 0.32 0.02  
Patients Normo 0.74 0.24 0.02 
Non-normo 0.52 0.43 0.05 
XRCC1 
Arg399Gln 
 Arg/Arg Arg/Gln Gln/Gln  
Donors 0.28 0.56 0.16  
Patients Normo 0.50 0.33 0.17 
Non-normo 0.44 0.45 0.11 
 
 
Table 6: Distribution of the genotype frequencies for the 9 possible combinations of the OGG1 
Ser326Cys and XRCC1 Arg399Gln polymorphisms. OR= Odds ratio.  
 
Patients Donors   
Genotypes n (obs) % n (obs) % P-value OR (95% CI) 
OGG1 
Ser326Cys 
XRCC1 
Arg399Gln 
Ser/Ser Arg/Arg 85 27.4 13 16.5 0.045 1.915 (1.005-3.648) 
Ser/Ser Arg/Gln 77 24.7 31 38 0.016 0.531 (0.315-0.894) 
Ser/Ser Gln/Gln 20 6.4 9 11.4 0.127 0.529 (0.231-1.212) 
Ser/Cys Arg/Arg 55 17.5 10 12.7 0.299 1.465 (0.710-3.023) 
Ser/Cys Arg/Gln 44 14 11 13.9 0.984 1.007 (0.494-2.054) 
Ser/Cys Gln/Gln 19 6.1 4 5.1 0.738 1.208 (0.399-3.656) 
Cys/Cys Arg/Arg 4 1.3 0 0 - - 
Cys/Cys Arg/Gln 8 2.5 2 2.5 0.994 1.007 (0.210-4.836) 
Cys/Cys Gln/Gln 1 0.3 0 0 - - 
 
0.002 
 0.006 
 
